Single Arm Prospective Trial on BOLD fMRI Radiation-Induced Changes in Newly Diagnosed Glioblastoma Patients

被引：0
|
作者：
Buss, E. J. [1 ]
Wu, P. B. [2 ]
Yanagihara, T. [3 ]
Grinband, J. [4 ]
Wang, T. J. C. [1 ,5 ]
机构：
[1] Columbia Univ, Dept Radiat Oncol, Irving Med Ctr, New York, NY USA
[2] Columbia Univ, Vagelos Coll Phys & Surg, New York, NY USA
[3] Univ N Carolina, Sch Med, Dept Radiat Oncol, Eden, NC USA
[4] Columbia Univ, Dept Radiol, Irving Med Ctr, New York, NY USA
[5] Columbia Univ, Herbert Irving Comprehens Canc Ctr, Irving Med Ctr, New York, NY USA
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2021年 / 111卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
30
引用
收藏
页码：S16 / S17
页数：2
相关论文
共 50 条
  • [1] MRI changes in patients with newly diagnosed glioblastoma treated as part a Phase II trial with bavituximab, radiation, and temozolomide
    Ly, Ina
    Cardona, Jonathan
    Beers, Andrew
    Chang, Ken
    Brown, James
    Reardon, David
    Arrillaga-Romany, Isabel
    Dietrich, Jorg
    Forst, Deborah
    Lee, Eudocia
    Jordan, Justin
    Nayak, Lakshmi
    Wen, Patrick
    Batchelor, Tracy
    Curry, William
    Kalpathy-Cramer, Jayashree
    Gerstner, Elizabeth
    NEUROLOGY, 2019, 92 (15)
  • [2] MRI CHANGES IN NEWLY DIAGNOSED GLIOBLASTOMA PATIENTS TREATED AS PART OF A PHASE II TRIAL WITH BAVITUXIMAB, RADIATION, AND TEMOZOLOMIDE
    Ly, Ina
    Cardona, Jonathan
    Beers, Andrew
    Chang, Ken
    Brown, James
    Reardon, David
    Arrillaga-Romany, Isabel
    Dietrich, Jorg
    Forst, Deborah
    Lee, Eudocia
    Jordan, Justin
    Nayak, Lakshmi
    Wen, Patrick
    Batchelor, Tracy
    Kalpathy-Cramer, Jayashree
    Gerstner, Elizabeth
    NEURO-ONCOLOGY, 2018, 20 : 191 - 191
  • [3] A clinical trial of bevacizumab, temozolomide, and radiation for newly diagnosed glioblastoma
    Narayana, Ashwatha
    Gruber, Deborah
    Kunnakkat, Saroj
    Golfinos, John G.
    Parker, Erik
    Raza, Shahzad
    Zagzag, David
    Eagan, Patricia
    Gruber, Michael L.
    JOURNAL OF NEUROSURGERY, 2012, 116 (02) : 341 - 345
  • [4] Phase II trial of erlotinib with temozolomide and radiation in patients with newly diagnosed glioblastoma multiforme
    David M. Peereboom
    Dale R. Shepard
    Manmeet S. Ahluwalia
    Cathy J. Brewer
    Neeraj Agarwal
    Glen H. J. Stevens
    John H. Suh
    Steven A. Toms
    Michael A. Vogelbaum
    Robert J. Weil
    Paul Elson
    Gene H. Barnett
    Journal of Neuro-Oncology, 2010, 98 : 93 - 99
  • [5] Phase II trial of erlotinib with temozolomide and radiation in patients with newly diagnosed glioblastoma multiforme
    Peereboom, David M.
    Shepard, Dale R.
    Ahluwalia, Manmeet S.
    Brewer, Cathy J.
    Agarwal, Neeraj
    Stevens, Glen H. J.
    Suh, John H.
    Toms, Steven A.
    Vogelbaum, Michael A.
    Weil, Robert J.
    Elson, Paul
    Barnett, Gene H.
    JOURNAL OF NEURO-ONCOLOGY, 2010, 98 (01) : 93 - 99
  • [6] Efficacy and safety of anlotinib combined with the STUPP regimen in patients with newly diagnosed glioblastoma: a multicenter, single-arm, phase Ⅱ trial
    Shuzhen Lai
    Peijing Li
    Xiaohui Liu
    Guihong Liu
    Tieming Xie
    Xing Zhang
    Xiaoxuan Wang
    Jing Huang
    Yiqiang Tang
    Zhigang Liu
    Guoping Shen
    Chaoming Li
    Fangxiao Lu
    Lei Wang
    Fagui Jiang
    Caixing Sun
    Yuanyuan Chen
    Ming Chen
    Cancer Biology & Medicine, 2024, 21 (05) : 433 - 444
  • [7] MRI changes in patients with newly diagnosed glioblastoma treated as part of a phase II trial with bavituximab, radiation, and temozolomide.
    Ly, Ina
    Cardona, Jonathan
    Lou, Kevin
    Beers, Andrew
    Chang, Ken
    Brown, James
    Reardon, David A.
    Arrillaga-Romany, Isabel
    Forst, Deborah Anne
    Jordan, Justin T.
    Lee, Eudocia Quant
    Dietrich, Jorg
    Nayak, Lakshmi
    Wen, Patrick Y.
    Chukwueke, Ugonma Nnenna
    Batchelor, Tracy
    Curry, William T.
    Kalpathy-Cramer, Jayashree
    Gerstner, Elizabeth Robins
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [8] Neoadjuvant pamiparib in patients with newly diagnosed advanced ovarian cancer: A single-arm, prospective phase II trial
    Liu, Jing
    Hu, Dan
    Li, Li
    Zang, Lele
    Zhu, Fei
    Zhu, Mingxuan
    Zhang, Huiqi
    Chang, Lele
    Xu, Qin
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [9] Final data from the phase 2a single-arm trial of SurVaxM for newly diagnosed glioblastoma
    Ciesielski, Michael J.
    Ahluwalia, Manmeet Singh
    Reardon, David A.
    Abad, Ajay P.
    Curry, William T.
    Wong, Eric T.
    Peereboom, David M.
    Figel, Sheila A.
    Hutson, Alan
    Groman, Adrienne
    Withers, Henry G.
    Liu, Song
    Belal, Ahmed
    Qiu, Jing-Xin
    Mogensen, Kathleen
    Schilero, Cathy
    Casucci, Danielle M.
    Mechtler, Laszlo
    Fenstermaker, Robert Alan
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [10] Efficacy and safety of anlotinib combined with the STUPP regimen in patients with newly diagnosed glioblastoma: a multicenter, single-arm, phase II trial
    Lai, Shuzhen
    Li, Peijing
    Liu, Xiaohui
    Liu, Guihong
    Xie, Tieming
    Zhang, Xing
    Wang, Xiaoxuan
    Huang, Jing
    Tang, Yiqiang
    Liu, Zhigang
    Shen, Guoping
    Li, Chaoming
    Lu, Fangxiao
    Wang, Lei
    Jiang, Fagui
    Sun, Caixing
    Chen, Yuanyuan
    Chen, Ming
    CANCER BIOLOGY & MEDICINE, 2024, 21 (05)
12345